**Although it was feared that Cannabis exports would decline because of the pandemic. To everyone’s surprise, they were successfully increased for Uruguay
The medical cannabis industry is currently at a winning pace. Despite the incidences caused by the pandemic, Uruguay has achieved great export opportunities. The first step was the legalization but another difference would be to be able to compete in the market of the exports.
When approving the law of medical cannabis it was not raised at the moment that Uruguay could become an exporter because no country was importing these types of products. Nevertheless, although they have presented/displayed disadvantages, there are many political parties that have shown great support and solidarity towards the industry of cannabis.
This obtained that against all prognosis, the exports of cannabis raised instead of lowering. Second opportunities in the market were found abroad, like for example many companies exported US $2 million in flowers with low content of THC, that is to say not psychoactive cannabis, all this directed to Switzerland. This thanks to the embassies and authorities joined to open the Swiss market for this product, which turned out to be very clever.
On the other hand, in addition to the flowers, the medicinal oil Epifractan of MediPlast is being sold. One of the few medicines derived from cannabis that is registered in Uruguay, which is exported to several countries in the region, especially Brazil and Argentina. Likewise, in the last two years, MediPlast has been able to sell more than US $200 thousand of this product.
According to experts in the field according to The Observer, in order for Uruguay to continue to grow and prosper in the cannabis industry, it should develop the medical market on a national level. In this way, it would gain more commercial opportunities within the country, as well as for research to continue to evidence the medicinal and therapeutic properties of cannabis.